Asset Details
Do you wish to reserve the book?
Transplantation of ex vivo Expanded Endothelial Progenitor Cells for Therapeutic Neovascularization
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Transplantation of ex vivo Expanded Endothelial Progenitor Cells for Therapeutic Neovascularization
Do you wish to request the book?
Transplantation of ex vivo Expanded Endothelial Progenitor Cells for Therapeutic Neovascularization
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Transplantation of ex vivo Expanded Endothelial Progenitor Cells for Therapeutic Neovascularization
2000
Overview
Animal studies and preliminary results in humans suggest that lower extremity and myocardial ischemia can be attenuated by treatment with angiogenic cytokines. The resident population of endothelial cells that is competent to respond to an available level of angiogenic growth factors, however, may potentially limit the extent to which cytokine supplementation enhances tissue neovascularization. Accordingly, we transplanted human endothelial progenitor cells (hEPCs) to athymic nude mice with hindlimb ischemia. Blood flow recovery and capillary density in the ischemic hindlimb were markedly improved, and the rate of limb loss was significantly reduced. Ex vivo expanded hEPCs may thus have utility as a \"supply-side\" strategy for therapeutic neovascularization.
